News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioMerieux To Phase Out Some Microplate Production



12/20/2006 10:21:32 AM

PARIS, Dec 20 (Reuters) - BioMerieux (BIOX.PA: Quote, Profile , Research), a French company that makes healthcare tests, said it would phase out production of microplate immunoassay at a facility in North Carolina next year, leading to a charge of around 7 million euros ($9.2 million) in its 2006 accounts. BioMerieux added in a statement released late on Tuesday that the charges would be mainly due to restructuring provisions, although the decision was not expected to have a material impact on the 2007 accounts. The business being phased out comprised tests used to diagnose HIV and Human T-Cell Lymphotropic Virus primarily in reference laboratories and blood banks, the company said.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES